-
Human medicines European public assessment report (EPAR): Inflectra, infliximab, Date of authorisation: 10/09/2013, Revision: 30, Status: Authorised
18 Apr 2024 16:54 GMT
… response to disease?modifying antirheumatic drugs (DMARDs), including methotrexate, has … to or have medical contraindications for such therapies;
treatment of fistulising, … to other systemic therapy including cyclosporine, methotrexate or psoralen ultra- …
-
Calliditas Therapeutics Presents Additional Data Analyses from the Phase 3 NeflgArd trial of Nefecon in Primary IgA Nephropathy at the ISN World Congress of Nephrology 2024
18 Apr 2024 14:19 GMT
… said Richard Philipson, Chief Medical Officer of Calliditas. … 3 trial"
During the 9-month treatment period, … immune response to some vaccines.
Other corticosteroid effects: … , saquinavir, erythromycin, and cyclosporine. Avoid ingestion of grapefruit …
-
Epidemiology, Microbiology, and Risk Factors of Bacterial Bloodstream Infections in Patients After Allogeneic Hematopoietic Stem Cell Transplantation
20 Apr 2024 07:43 GMT
… . Standard GVHD prophylaxis included either Cyclosporine A (CsA) or Tacrolimus … and the drugs could be considered a good treatment choice as … Society of Hematology, Chinese Medical Association; Chinese Medical Doctor Association, Hematology Branch. Chinese …
-
Birth Control Pills
16 Apr 2024 22:18 GMT
… the use of this drug. Call your doctor for medical advice about serious … the FDA at 1-800-FDA-1088.
List of birth control pill brands … pills?
Estrogens can inhibit the metabolism (elimination) of cyclosporine, resulting in increased cyclosporine …
-
Next-gen ocular therapeutics to optimize healing and comfort in canine patients
19 Apr 2024 19:20 GMT
Sponsored by Sentrx Animal Care
Video transcript:
Adam Christman, DVM, MBA: Hey everyone, Dr. Adam Christman here, Chief Editor and Officer for DVM 360. Welcome to Products 360. We're so honored to be here at Charlotte Animal Referral and Emergency …
-
Ocular Therapeutix™ Announces Positive Topline Phase 1 Data for AXPAXLI™ in Diabetic Retinopathy
18 Apr 2024 11:00 GMT
… arm received rescue medication
Next Steps: Positive … drug product, DEXTENZA®, an FDA-approved corticosteroid for the treatment … CSI (cyclosporine intracanalicular insert) for the chronic treatment … clinical trials, including the SOL-1 trial, the HELIOS trial, …
-
New AAD Atopic Dermatitis Guidelines and Dupilumab Label Updates
16 Apr 2024 15:11 GMT
… Rinvoq); conditionally recommend phototherapy, cyclosporine, methotrexate, azathioprine, and … 3 LIBERTY-AD-HAFT trial (NCT04417894), a double … more diversity in clinical trials. “It’s … in dermatology treatment. “When discussing treatment options, it …
-
Ocular Therapeutix™ Strengthens Clinical Team with Appointment of Key Retinal Leaders
16 Apr 2024 11:00 GMT
… Ophthalmology Medical Affairs team as an Executive Director at Regeneron Pharmaceuticals, Inc … first commercial drug product, DEXTENZA®, an FDA-approved corticosteroid for the treatment of … clinical trials, including the SOL-1 trial, the planned SOL-2 trial …
-
New Novartis Fabhalta® (iptacopan) data show clinically meaningful and statistically significant proteinuria reduction of 38.3% versus placebo for patients with IgA nephropathy (IgAN)
16 Apr 2024 03:33 GMT
… renal portfolio at future medical meetings.
About APPLAUSE-IgAN … approved drugs or initiating new background therapy for treatment of … development and introduction of cyclosporine helped reimagine the field … .html
SOURCE Novartis Pharmaceuticals Corporation
-
Regulatory tracker: Takeda's subcutaneous Entyvio scores FDA approval in Crohn's disease
03 Jan 2024 17:45 GMT
… three phase 3 trials.
After a July rejection, Citius Pharmaceuticals is once again seeking FDA approval for its … final draft guidance recommending the medicine, plus diet and other LDL-C therapies, for the treatment of adults and children …